The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, the market is projected to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.86% during 2023-2032. The rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits represent some of the key factors driving the market.
Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.
In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth.
Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) - based mobile applications that can diagnose STDs by analyzing digital images of an individual’s private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.
According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.
Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.
Sexually Transmitted Disease (STD) Diagnostics Market Trends
The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients.In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth.
Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) - based mobile applications that can diagnose STDs by analyzing digital images of an individual’s private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.
Key Market Segmentation
This report provides an analysis of the key trends in each segment of the global sexually transmitted disease (STD) diagnostics market report, along with forecasts at the global, regional and country levels from 2024-2032. The report has categorized the market based on type, device type, and end user.Type Insights:
- Chlamydia Testing
- Syphilis Testing
- Gonorrhea Testing
- Herpes Simplex Virus Testing
- Human Papilloma Virus Testing
- Human Immunodeficiency Virus Testing
- Chancroid Testing
- Others
Device Type Insights:
- Laboratory Devices
- Thermal Cycler - PCR
- Lateral Flow Readers
- Flow Cytometers
- Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
- Others
- Point of Care (PoC) Devices
- Phone Chips (Microfluidics + ICT)
- Portable/Bench Top/Rapid Diagnostic Kits
End User Insights:
- Laboratory Testing
- Point of Care (PoC) Testing
Regional Insights:
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
- What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
- What are the key regional markets?
- Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
- What is the breakup of the market based on the type?
- Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
- What is the breakup of the market based on the device type?
- Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
- What is the breakup of the market based on end user?
- Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
- What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
- Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Sexually Transmitted Disease (STD) Diagnostics Market
6 Market Breakup by Type
7 Market Breakup by Device Type
8 Market Breakup by End User
9 Market Breakup by Region
10 Drivers, Restraints, and Opportunities
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Becton Dickinson and Company
- BioMérieux SA
- Bio-Rad Laboratories Inc.
- Cepheid (Danaher Corporation)
- F. Hoffmann-La Roche AG
- Hologic Inc.
- Qiagen N.V.
- Quidel Corporation
- Siemens Healthineers AG (Siemens AG)
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 137 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 104.1 Billion |
| Forecasted Market Value ( USD | $ 159.5 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
